BSE Live
Dec 26, 16:01Prev. Close
1737.50
Open Price
1727.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 26, 15:54Prev. Close
1737.00
Open Price
1737.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1719.50 (503)
| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 45.60 | 39.90 | 35.30 | 13.60 | 12.10 | |
| Diluted EPS (Rs.) | 45.60 | 39.90 | 35.30 | 13.60 | 12.10 | |
| Cash EPS (Rs.) | 56.50 | 50.87 | 46.22 | 23.13 | 18.19 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 301.00 | 265.36 | 247.22 | 212.84 | 206.23 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 301.00 | 265.36 | 247.22 | 212.84 | 206.23 | |
| Revenue from Operations/Share (Rs.) | 219.14 | 202.13 | 182.91 | 161.11 | 139.62 | |
| PBDIT/Share (Rs.) | 71.84 | 59.92 | 51.19 | 47.18 | 38.87 | |
| PBIT/Share (Rs.) | 61.11 | 49.27 | 40.64 | 38.24 | 30.20 | |
| PBT/Share (Rs.) | 57.32 | 46.21 | 39.21 | 18.68 | 11.67 | |
| Net Profit/Share (Rs.) | 45.76 | 40.21 | 35.68 | 14.20 | 9.52 | |
| NP After MI And SOA / Share (Rs.) | 45.55 | 39.91 | 35.32 | 13.64 | 12.10 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 32.78 | 29.64 | 27.98 | 29.28 | 27.84 | |
| PBIT Margin (%) | 27.88 | 24.37 | 22.22 | 23.73 | 21.63 | |
| PBT Margin (%) | 26.15 | 22.86 | 21.43 | 11.59 | 8.35 | |
| Net Profit Margin (%) | 20.88 | 19.89 | 19.50 | 8.81 | 6.82 | |
| NP After MI And SOA Margin (%) | 20.78 | 19.74 | 19.30 | 8.46 | 8.66 | |
| Return on Networth/Equity (%) | 15.13 | 15.04 | 15.13 | 6.81 | 6.24 | |
| Return on Capital Employed (%) | 19.83 | 17.26 | 16.02 | 17.44 | 14.06 | |
| Return on Assets (%) | 11.86 | 11.20 | 10.49 | 4.68 | 4.29 | |
| Total Debt/Equity (X) | 0.03 | 0.04 | 0.11 | 0.02 | 0.07 | |
| Asset Turnover Ratio (%) | 0.59 | 0.58 | 0.58 | 0.56 | 0.49 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.89 | 2.56 | 2.00 | 2.04 | 1.89 | |
| Quick Ratio (X) | 2.33 | 1.98 | 1.48 | 1.51 | 1.33 | |
| Inventory Turnover Ratio (X) | 5.23 | 4.76 | 0.80 | 0.78 | 0.73 | |
| Dividend Payout Ratio (NP) (%) | 33.06 | 30.26 | 29.73 | 65.96 | 53.68 | |
| Dividend Payout Ratio (CP) (%) | 26.76 | 23.88 | 22.89 | 39.85 | 31.28 | |
| Earnings Retention Ratio (%) | 66.94 | 69.74 | 70.27 | 34.04 | 46.32 | |
| Cash Earnings Retention Ratio (%) | 73.24 | 76.12 | 77.11 | 60.15 | 68.72 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 74.50 | 60.29 | 71.40 | 88.88 | 65.95 | |
| Interest Coverage Ratios (Post Tax) (%) | 74.50 | 60.29 | 71.40 | 88.88 | 65.95 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 407,192.46 | 384,570.80 | 239,622.86 | 218,440.19 | 143,296.74 | |
| EV/Net Operating Revenue (X) | 7.74 | 7.93 | 5.46 | 5.65 | 4.28 | |
| EV/EBITDA (X) | 23.62 | 26.75 | 19.51 | 19.30 | 15.36 | |
| MarketCap/Net Operating Revenue (X) | 7.92 | 8.02 | 5.37 | 5.68 | 4.28 | |
| Retention Ratios (%) | 66.93 | 69.73 | 70.26 | 34.03 | 46.31 | |
| Price/BV (X) | 5.77 | 6.11 | 4.21 | 4.57 | 3.09 | |
| Price/Net Operating Revenue | 7.92 | 8.02 | 5.37 | 5.68 | 4.28 | |
| Earnings Yield | 0.03 | 0.02 | 0.04 | 0.01 | 0.02 |
20.11.2025
12.11.2025
11.11.2025
Buy Sun Pharmaceutical Industries; target of Rs 1875 Prabhudas Lilladher
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
11.11.2025
Sun Pharma Standalone September 2025 Net Sales at Rs 4,548.11 crore, down 11.3% Y-o-Y
01.08.2025
Sun Pharma Consolidated June 2025 Net Sales at Rs 13,851.40 crore, up 9.47% Y-o-Y
31.07.2025
Sun Pharma Standalone June 2025 Net Sales at Rs 5,601.96 crore, up 24.54% Y-o-Y
22.05.2025
Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend